Clinuvel Pharmaceuticals (CUV) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Clinuvel Pursues Expanded SCENESSE® Dosage in EuropeNovember 20, 2024 | markets.businessinsider.comClinuvel Pharmaceuticals Tackles Market Challenges and OpportunitiesNovember 18, 2024 | markets.businessinsider.comClinuvel Pharmaceuticals Refocuses on Core Programs for GrowthNovember 18, 2024 | markets.businessinsider.comMA Financial Group Sticks to Its Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)October 30, 2024 | markets.businessinsider.comHealth Check: 4D Medical investors – and burns pit victims – can breathe easier after US lung-imaging dealOctober 1, 2024 | msn.comTop Growth Companies With Significant Insider OwnershipSeptember 28, 2024 | finance.yahoo.comSeptember 2024's Top Growth Picks With High Insider OwnershipSeptember 20, 2024 | finance.yahoo.comClinuvel Pharmaceuticals (ASX:CUV) Posted Healthy Earnings But There Are Some Other Factors To Be Aware OfSeptember 11, 2024 | finance.yahoo.com3 High Growth ASX Companies With Significant Insider OwnershipSeptember 8, 2024 | finance.yahoo.comAnalysts Are Bullish on These Healthcare Stocks: Impedimed Limited (IPDQF), Clinuvel Pharmaceuticals Limited (CLVLF)September 4, 2024 | markets.businessinsider.comClinuvel Pharmaceuticals Full Year 2024 Earnings: Beats ExpectationsSeptember 2, 2024 | finance.yahoo.comClinuvel Pharmaceuticals Limited (CUV.AX)September 2, 2024 | ca.finance.yahoo.comGuess which ASX All Ords healthcare share just rocketed 13% on its FY 2024 results!August 29, 2024 | msn.comMorgans upgrades Clinuvel Pharmaceuticals Limited (CLVLF) to a BuyAugust 26, 2024 | markets.businessinsider.comWhere to find value opportunities in Australian healthcare and 3 stocks to watchAugust 8, 2024 | msn.com3 High Insider Ownership Growth Companies With 18% Revenue IncreaseJuly 26, 2024 | finance.yahoo.comHigh Insider Ownership Growth Stocks On The ASX For July 2024July 24, 2024 | finance.yahoo.comiShares Gold Producers UCITS ET (IS0E.SG)May 4, 2024 | finance.yahoo.com2 undiscovered stocks (and how to analyse under-the-radar companies)April 28, 2024 | msn.comMalibu shines a light on CLINUVEL’s pioneering work in photomedicineMarch 5, 2024 | finance.yahoo.comDr Boreham’s Crucible: Does Clinuvel’s investor value run deeper than just ‘makes Scenesse’?March 4, 2024 | msn.comClinuvel Pharmaceuticals Ltd CUVFebruary 28, 2024 | morningstar.comWhy Clinuvel, Medibank, Sayona Mining, and Tabcorp shares are sinking todayFebruary 22, 2024 | fool.com.auAustralia stocks higher at close of trade; S&P/ASX 200 up 0.04%February 22, 2024 | msn.comShort & Caught: Pilbara Minerals ASX’s most shorted as lithium stocks targetedJanuary 3, 2024 | msn.comLooking for ASX growth shares to buy? These could rise ~30%December 7, 2023 | fool.com.auDown 25% in a month, is this ASX 300 company about to sue the UK Government?September 20, 2023 | fool.com.auWhy the Clinuvel Pharmaceuticals share price crashed 11% lower todaySeptember 1, 2023 | fool.com.auWilsons Sticks to Its Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)September 1, 2023 | markets.businessinsider.comClinuvel Pharmaceuticals Limited (CLVLF) Gets a Buy from WilsonsMay 4, 2023 | markets.businessinsider.comWILSONS Maintains Clinuvel Pharmaceuticals (ASX:CUV) Overweight RecommendationApril 21, 2023 | msn.comInstitutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV) shares but individual investors control 54% of the companyApril 16, 2023 | finance.yahoo.comWilsons Sticks to Their Buy Rating for Clinuvel Pharmaceuticals Limited (CLVLF)April 4, 2023 | markets.businessinsider.comHere's Why We Think Clinuvel Pharmaceuticals (ASX:CUV) Might Deserve Your Attention TodayMarch 14, 2023 | finance.yahoo.comCUV.AX - | Stock Price & Latest News | ReutersFebruary 7, 2023 | reuters.comCLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned IndividualsFebruary 1, 2023 | finance.yahoo.comClinuvel Pharmaceuticals Limited: CLINUVEL Trial Results Show Drug Reduces DNA DamageJanuary 16, 2023 | finanznachrichten.deClinuvel Pharmaceuticals Limited's (ASX:CUV) Stock Has Fared Decently: Is the Market Following Strong Financials?November 24, 2022 | finance.yahoo.comClinuvel Pharmaceuticals LimitedNovember 18, 2022 | afr.comWhile institutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV), individual investors are its largest shareholders with 54% ownershipNovember 7, 2022 | finance.yahoo.comClinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Compensation Is Looking A Bit Stretched At The MomentOctober 20, 2022 | finance.yahoo.comWhy did this ASX 200 healthcare share rocket 16% today?August 31, 2022 | fool.com.auWhy CLINUVEL and these ASX shares have doubled in value in 12 monthsJuly 27, 2022 | fool.com.auClinuvel Pharmaceuticals shares higher on strong quarterly sales growthJuly 18, 2022 | fool.com.auHere’s why these 4 ASX shares rocketed higher todayJuly 6, 2022 | fool.com.auPositive final results in strokeMay 3, 2022 | finance.yahoo.comAustralia stocks higher at close of trade; S&P/ASX 200 up 0.26%March 25, 2022 | msn.comWhy is the Clinuvel (ASX:CUV) share price zooming 6% higher today?March 15, 2022 | msn.comAre Investors Undervaluing Clinuvel Pharmaceuticals Limited (ASX:CUV) By 24%?March 4, 2022 | finance.yahoo.comWill Weakness in Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock Prove Temporary Given Strong Fundamentals?January 2, 2022 | finance.yahoo.com Get Clinuvel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CUV and its competitors with MarketBeat's FREE daily newsletter. Email Address Cackling Kamala hates this company (Ad)Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. CUV Media Mentions By Week CUV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CUV News Sentiment▼0.000.60▲Average Medical News Sentiment CUV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CUV Articles This Week▼00▲CUV Articles Average Week Get Clinuvel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CUV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Apollomics News Today Arno Therapeutics News Today Ascentage Pharma Group International News Today Ascletis Pharma News Today Avacta Group News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:CUV) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clinuvel Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Clinuvel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.